These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 20718038)
1. A mutant form of PTEN linked to autism. Redfern RE; Daou MC; Li L; Munson M; Gericke A; Ross AH Protein Sci; 2010 Oct; 19(10):1948-56. PubMed ID: 20718038 [TBL] [Abstract][Full Text] [Related]
2. Membrane association of the PTEN tumor suppressor: molecular details of the protein-membrane complex from SPR binding studies and neutron reflection. Shenoy S; Shekhar P; Heinrich F; Daou MC; Gericke A; Ross AH; Lösche M PLoS One; 2012; 7(4):e32591. PubMed ID: 22505997 [TBL] [Abstract][Full Text] [Related]
3. PTEN phosphatase selectively binds phosphoinositides and undergoes structural changes. Redfern RE; Redfern D; Furgason ML; Munson M; Ross AH; Gericke A Biochemistry; 2008 Feb; 47(7):2162-71. PubMed ID: 18220422 [TBL] [Abstract][Full Text] [Related]
4. Allosteric activation of PTEN phosphatase by phosphatidylinositol 4,5-bisphosphate. Campbell RB; Liu F; Ross AH J Biol Chem; 2003 Sep; 278(36):33617-20. PubMed ID: 12857747 [TBL] [Abstract][Full Text] [Related]
5. A short N-terminal sequence of PTEN controls cytoplasmic localization and is required for suppression of cell growth. Denning G; Jean-Joseph B; Prince C; Durden DL; Vogt PK Oncogene; 2007 Jun; 26(27):3930-40. PubMed ID: 17213812 [TBL] [Abstract][Full Text] [Related]
6. A voltage-sensing phosphatase, Ci-VSP, which shares sequence identity with PTEN, dephosphorylates phosphatidylinositol 4,5-bisphosphate. Iwasaki H; Murata Y; Kim Y; Hossain MI; Worby CA; Dixon JE; McCormack T; Sasaki T; Okamura Y Proc Natl Acad Sci U S A; 2008 Jun; 105(23):7970-5. PubMed ID: 18524949 [TBL] [Abstract][Full Text] [Related]
7. The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif. Walker SM; Leslie NR; Perera NM; Batty IH; Downes CP Biochem J; 2004 Apr; 379(Pt 2):301-7. PubMed ID: 14711368 [TBL] [Abstract][Full Text] [Related]
8. Biophysical methods for the characterization of PTEN/lipid bilayer interactions. Harishchandra RK; Neumann BM; Gericke A; Ross AH Methods; 2015 May; 77-78():125-35. PubMed ID: 25697761 [TBL] [Abstract][Full Text] [Related]
9. Defining the membrane-associated state of the PTEN tumor suppressor protein. Lumb CN; Sansom MS Biophys J; 2013 Feb; 104(3):613-21. PubMed ID: 23442912 [TBL] [Abstract][Full Text] [Related]
10. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes. Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863 [TBL] [Abstract][Full Text] [Related]
12. Localization of agonist-sensitive PtdIns(3,4,5)P3 reveals a nuclear pool that is insensitive to PTEN expression. Lindsay Y; McCoull D; Davidson L; Leslie NR; Fairservice A; Gray A; Lucocq J; Downes CP J Cell Sci; 2006 Dec; 119(Pt 24):5160-8. PubMed ID: 17158918 [TBL] [Abstract][Full Text] [Related]
13. Phospholipid-binding sites of phosphatase and tensin homolog (PTEN): exploring the mechanism of phosphatidylinositol 4,5-bisphosphate activation. Wei Y; Stec B; Redfield AG; Weerapana E; Roberts MF J Biol Chem; 2015 Jan; 290(3):1592-606. PubMed ID: 25429968 [TBL] [Abstract][Full Text] [Related]
14. A126 in the active site and TI167/168 in the TI loop are essential determinants of the substrate specificity of PTEN. Leitner MG; Hobiger K; Mavrantoni A; Feuer A; Oberwinkler J; Oliver D; Halaszovich CR Cell Mol Life Sci; 2018 Nov; 75(22):4235-4250. PubMed ID: 29987362 [TBL] [Abstract][Full Text] [Related]
15. Tumor suppression by PTEN requires the activation of the PKR-eIF2alpha phosphorylation pathway. Mounir Z; Krishnamoorthy JL; Robertson GP; Scheuner D; Kaufman RJ; Georgescu MM; Koromilas AE Sci Signal; 2009 Dec; 2(102):ra85. PubMed ID: 20029030 [TBL] [Abstract][Full Text] [Related]
16. A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN. Rahdar M; Inoue T; Meyer T; Zhang J; Vazquez F; Devreotes PN Proc Natl Acad Sci U S A; 2009 Jan; 106(2):480-5. PubMed ID: 19114656 [TBL] [Abstract][Full Text] [Related]
17. Identification of a PTEN mutation with reduced protein stability, phosphatase activity, and nuclear localization in Hong Kong patients with autistic features, neurodevelopmental delays, and macrocephaly. Wong CW; Or PMY; Wang Y; Li L; Li J; Yan M; Cao Y; Luk HM; Tong TMF; Leslie NR; Lo IF; Choy KW; Chan AML Autism Res; 2018 Aug; 11(8):1098-1109. PubMed ID: 29608813 [TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Lee JO; Yang H; Georgescu MM; Di Cristofano A; Maehama T; Shi Y; Dixon JE; Pandolfi P; Pavletich NP Cell; 1999 Oct; 99(3):323-34. PubMed ID: 10555148 [TBL] [Abstract][Full Text] [Related]
19. Membrane association of the PTEN tumor suppressor: electrostatic interaction with phosphatidylserine-containing bilayers and regulatory role of the C-terminal tail. Shenoy SS; Nanda H; Lösche M J Struct Biol; 2012 Dec; 180(3):394-408. PubMed ID: 23073177 [TBL] [Abstract][Full Text] [Related]
20. A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes. Rodríguez-Escudero I; Oliver MD; Andrés-Pons A; Molina M; Cid VJ; Pulido R Hum Mol Genet; 2011 Nov; 20(21):4132-42. PubMed ID: 21828076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]